BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) announced today that J.J. Finkelstein, RegeneRx’s president and chief executive officer, will present a company update at the Rodman & Renshaw Annual Global Investment Conference in New York at 10:20 a.m. ET on Tuesday, November 11. To listen and view the presentation investors may either visit RegeneRx’s homepage at www.regenerx.com or click on the following link: http://www.wsw.com/webcast/rrshq14/rgn. An archived copy of the presentation will be available on RegeneRx’s website.
